Citation: | LIU Weizhong, HE Guangwei, WANG Yinhu, HE Jianxun, WANG Kui. Synthesis of 1-(4-methylbenzyl)-2-methyl-octahydro-isoquinoline hydrochloride[J]. Journal of China Pharmaceutical University, 2016, 47(5): 548-550. DOI: 10.11665/j.issn.1000-5048.20160507 |
[1] |
Murakami M,Kawahara S,Inukai N,et al.Studies on morphinan derivatives.II.The synthesis of d-3-methyl-N-methylmorphinan,a new antitussive[J].Chem Pharm Bull,1972,20(8):1706-1710.
|
[2] |
Schnider O,Hellerbach J.Synthese von morphinanen.(2.Mitteilung)[J].Helv Chim Acta,1950,33(6):1437-1448.
|
[3] |
Murakami M,Inukai N,Nagano N.Studies on morphinan derivatives.I.The synthesis of several new 3-substituted derivatives of N-methylmorphinan having antitussive activities[J].Chem Pharm Bull,1972,20(8):1699-1705.
|
[4] |
Gal J,Weinkam RJ,Castagnoli N.Synthesis of cis-and trans-1-(3,4-dimethoxybenzyl)-3,7-dimethyl-5,8-dimethoxy-1,2,3,4-tetrahydroxyisoquinoline.Mechanism of the Bischler-Napieralski reaction[J].J Org Chem,1974,39(3):418-421.
|
[5] |
Xu YJ,Wei XY,Cong JJ,et al.Tetralin isoquinoline compounds as well as preparation methods and applications thereof(四氢异喹啉类化合物及其制备方法和用途):CN,102134245 A[P].2011-07-27.
|
[6] |
Belsten JC,Dyke SF.4.Monofluoroisoquinolines.Part I[J].J Chem Soc,1964:22-26.
|
[7] |
Belsten JC, Dyke SF. Monofluoroisoquinolines. Part II[J]. J Chem Soc C,1968:2073-2075.
|
[8] |
Kametani T, Fukumoto K, Satoh F. The syntheses of isoquinoline alkaloids and related compounds by biogenetic type reactions[J].Bioorg Chem,1974,3(4):430-497.
|
[9] |
Cope AC, Burrows WD. Clarke—Eschweiler cyclization. Scope and mechanism 1a[J].J Org Chem,1966,31(10):3099-3103.
|
[10] |
Farkas E,Sunman CJ.Chiral synthesis of doxpicomine[J].J Org Chem,1985,50(7):1110-1112.
|
[1] | LI Zhenming, HUO Meirong, DENG Qidan, CHEN Dengjun, SUN Hongzhang. In vitro evaluation of saxagliptin and metformin hydrochloride sustained-release tablets[J]. Journal of China Pharmaceutical University, 2021, 52(5): 541-546. DOI: 10.11665/j.issn.1000-5048.20210505 |
[2] | ZHANG Jinlin, YUAN Yaozuo, ZHANG Ya, ZHAO Shuqiang, ZHAO Xun, ZHANG Mei. Consistency evaluation of domestic generic rifampicin capsules and reference drug in vitro[J]. Journal of China Pharmaceutical University, 2018, 49(5): 603-609. DOI: 10.11665/j.issn.1000-5048.20180513 |
[3] | Study on Optimize the Preparation and Formulation of Nimodipine-Containing Nanoliposome[J]. Journal of China Pharmaceutical University, 2003, (1): 27-30. |
[4] | Distribution of Nimodipine Microemulsion in Mice In vivo and Evaluation on Its Targeting Performance[J]. Journal of China Pharmaceutical University, 2002, (4): 31-34. |
[5] | Study on Transdermal Therapeutic System for Nimodipine[J]. Journal of China Pharmaceutical University, 2000, (5): 28-31. |
[6] | Development of Nimodipine Sustained Release Capsules[J]. Journal of China Pharmaceutical University, 1999, (5): 346-349. |
[7] | The Factors Influencing Nimodipine Release from Hydroxypropyl Methylcellulose Matrix Tablet[J]. Journal of China Pharmaceutical University, 1998, (6): 418-421. |
[8] | Improved Process of Nimodipine[J]. Journal of China Pharmaceutical University, 1998, (3): 82-83. |
[9] | Study on Penetration Enhancers for Nimodipine[J]. Journal of China Pharmaceutical University, 1994, (3): 149-152. |
[10] | CORRELATION BETWEEN THE ABSORPTION IN VIVO AND THE RELEASE IN VITRO OF TWO CONTROLLED-RELEASE TABLETS OF AMINOPHYLLINE[J]. Journal of China Pharmaceutical University, 1986, (1): 18-23. |